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Atypical ruminant pestiviruses are closely related to the two bovine viral diarrhoea virus (BVDV) species,
BVDV-1 and BVDV-2. While there is evidence of cross-protective immune responses between BVDV-1
and BVDV-2, despite antigenic differences, there is little information on the antigenic cross-reactivity
with atypical ruminant pestiviruses. The aim of this study was therefore to assess the specificity of anti-
body and T cell responses induced by experimental infection of calves with BVDV-1 strain Ho916,
Th/04_KhonKaen (TKK), an Asiatic atypical ruminant pestivirus, or co-infection with both viruses.
Homologous virus neutralization was observed in sera from both single virus infected and co-infected
groups, while cross-neutralization was only observed in the TKK infected group. T cell IFN-c responses
to both viruses were observed in the TKK infected animals, whereas Ho916 infected calves responded
better to homologous virus. Specifically, IFN-c responses to viral non-structural protein, NS3, were
observed in all infected groups while responses to viral glycoprotein, E2, were virus-specific. Broader
antigen-specific cytokine responses were observed with similar trends between inoculation groups and
virus species. The limited T cell and antibody immune reactivity of Ho916 inoculated animals to TKK sug-
gests that animals vaccinated with current BVDV-1-based vaccines may not be protected against atypical
ruminant pestiviruses.
Crown Copyright  2018 Published by Elsevier Ltd. All rights reserved.1. Introduction
The Pestivirus genus within the Flaviviridae family of single
stranded positive-sense RNA viruses comprises four recognized
species: BVDV-1, BVDV-2, classical swine fever virus (CSFV) and
border disease virus (BDV) [1]. Additionally, eight groups of unclas-
sified pestiviruses have been discovered: giraffe, pronghorn ante-
lope, Bungowannah, atypical ruminant, sheep, bat, rat and
atypical porcine pesitiviruses [2,3]. Atypical ruminant pestiviruses,
informally referred to as BVDV-3 or HoBi-like viruses, which form amonophyletic clade with a sister relationship to BVDV-1 and -2,
have been detected in contaminated foetal bovine serum (FBS)
and in natural infections in cattle and buffalo [4,5]. While the evi-
dence suggests atypical bovine pestiviruses are present in cattle in
South America, Southeast Asia and Europe, there is a need for
broader surveillance to assess the extent of their geographic distri-
bution and the possible impact on current and future BVDV control
programs.
Genetic and antigenic diversity of bovine pestiviruses may pose
a significant challenge to BVDV diagnosis and vaccination. Diagno-
sis by detection of viral material or through quantification of
virus-specific immune responses may be hampered by the
variability within these targets making it difficult to recognise
divergent or atypical viruses [6]. Furthermore, limited virus
cross-neutralization and failure in detection of seroconversion to
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evidence of significant antigenic diversity between atypical
pestiviruses and BVDV-1 and -2 [7]. This also raises questions
regarding the actual distribution of atypical pestiviruses and
potential efficacy of existing BVDV vaccines against these diver-
gent viruses. Whilst clinical cross-protection against BVDV-2 chal-
lenge has been reported using BVDV-1 vaccines, vaccination failure
has been attributed to virus diversity and inadequate protection
from foetal infection, postnatal infection and virus shedding [8,9].
In future, vaccines may have to be designed with protection
against BVDV-1 and -2 species and sub-genotypes as well as atyp-
ical bovine pestiviruses in mind [9]. This may be achieved by inclu-
sion of different virus genotypes/species, identification of targets of
cross-protective immune responses, or by the use of species-
specific vaccines.
This study, conducted as part of a study comparing the infection
kinetics and pathogenesis of calves experimentally infected with a
BVDV-1a strain (Ho916), an Asiatic atypical ruminant pestivirus
(Th/04_KhonKaen) or co-infection with both viruses, aimed to
assess whether antibody and T cell responses induced by one virus
were capable of responding to the heterologous virus and to deter-
mine if the immunodominant antigens, E2 glycoprotein and non-
structural protein NS3, were targets of cross-reactive or distinct
species-specific responses.2. Materials and methods
2.1. Viruses and animals
The study used the non-cytopathic BVDV-1a strain Ho916, iso-
lated from a clinically severe outbreak of BVD in the United King-
dom [10,11], and the non-cytopathic atypical bovine pestivirus
Th/04_KhonKaen (TKK), which was recovered from a dairy calf in
Thailand [12,13]. Both viruses were propagated in low passage foe-
tal bovine turbinate (fBT) cells and virus titres determined as the
median (50%) tissue culture infectious dose (TCID50) using the
Spearman-Kärber method following immunoperoxidase staining
[14]. Twenty 3–5 month old, BVDV-naïve Holstein calves were ran-
domly assigned into 4 groups of 5 animals. The calves were con-
firmed to be BVDV antibody and antigen negative to rule out
pre-exposure and persistent infection. Calves were inoculated with
105 TCID50 of Ho916, TKK or a mixture of both viruses (Ho916/
TKK). Each animal was inoculated with the appropriate virus or
viruses diluted in 10 mL EMEM (Invitrogen, Thermo Fisher Scien-
tific, Paisley, UK) by intranasal (5 mL) and intramuscular (5 mL)
routes simultaneously in 1 mL of EMEM (Invitrogen, Thermo Fisher
Scientific, Paisley, UK). Control animals (Controls) were similarly
inoculated with 10 mL of EMEM only. Assessment of clinical scores
including rectal temperature and sampling of blood and nasal
secretions was conducted up to 45 days post-infection (dpi). The
study was approved by the Ethics Committee for Animal Experi-
ments by the Ministry of Science and Higher Education in Poland
(No. 79/2010) and details of the procedures and outcome of the
experimental infection are previously described [15]. In brief,
milder clinical signs were observed in the TKK group and co-
infection resulted in prolonged pyrexia in comparison to the single
infection groups. Similar courses of viraemia were measured in all
three infected groups. Simultaneous detection of both viruses in
blood and nasal swabs was observed in the co-infected group. All
inoculated groups seroconverted two weeks after inoculation as
assessed by serum neutralisation of homologous virus. In addition
to Ho916 and TKK viruses, BVDV-1a C24V (C24V) [16], BVDV-2
502643-02-UK (BVDV-2) [17] and border disease virus 1 S137/4
(BDV-1) [18] reference strains were used to assess serological cross
reactivity.2.2. Detection of antibody responses
Competitive ELISAs were used for the detection of antibodies
against BVDV-1 NS3 (SVANOVIR BVDV p80, Svanova Biotech AB,
Uppsala, Sweden) and E2 (VDPro BVDV, Jeno Biotech, Chuncheon,
Republic of Korea) according to the manufacturer’s instructions.
Virus neutralizing antibody titres (VNT) in pooled serum samples
for each inoculation group at 42 dpi were determined against
Ho916, TKK, C24V, BVDV-2 and BDV-1 as described previously
[19]. VNT were calculated as reciprocal of the highest serum dilu-
tion that inhibited virus growth by 50% using the Spearman–
Kärber method and expressed on a log2 scale [14]. The extent of
cross-reactivity was calculated from log transformed VNTs as a
percentage of heterologous virus neutralisation compared to
homologous neutralisation [20].
2.3. Synthetic pestiviral peptides
Predicted amino acid sequences of Ho916 E2 and NS3 (GenBank
MH379638) were aligned against the reference strain C24V (Gen-
Bank AF091605.1) and Th/04_KhonKaen (GenBank FJ040215.1)
using the ClustalW algorithm on MegAlign (DNAStar Lasergene 9
Core Suite, Madison, WI, USA). Based on the divergence of the E2
and conservation of NS3 between the three viruses, overlapping
pentadecamer peptides offset by four residues (JPT Peptide Tech-
nologies, Berlin, Germany) were synthesised covering the complete
E2 protein from C24V, Ho916 and TKK (Fig. 1), and the NS3 protein
of C24V only (Fig. 2). Lyophilised peptides were dissolved in 0.1 M
HEPES pH 7.4-buffered 40% acetonitrile and pooled to represent
the respective E2 and NS3 proteins. Peptide pools were diluted in
RPMI-1640 medium supplemented with 2 mM L-glutamine, 20
mM HEPES, 100 U/mL penicillin, 100 lg/mL streptomycin, 50 mM
2-mercaptoethanol (all Invitrogen) and 10% FBS (Autogen Bioclear,
Calne, UK) (cRPMI).
2.4. Ex vivo stimulation of peripheral blood mononuclear cells and
assessment of cytokine responses
Peripheral blood mononuclear cells (PBMC) from calves were
isolated weekly from heparinised blood by density centrifugation
using Histopaque-1077 (Sigma, Poole, UK), suspended in cRPMI,
and added 5  105 cells/well to 96 well round-bottom plates. Cells
were stimulated in duplicate wells with 100 ll of peptide pools
representing the E2 and NS3 proteins at 1 lg/mL or viruses at a
multiplicity of infection of 1. Medium or mock-infected fBT super-
natant and pokeweed mitogen (Sigma) were used as negative and
positive controls respectively. The cells were incubated at 37 C for
48 h after which cell-free supernatants were harvested after cen-
trifugation and stored at 80 C until analysed. The release of
IFN-c in culture supernatants was measured using a bovine IFN-
c ELISA as previously described [21]. IFN-c, IL-4, IL-10 and MIP-
1b were simultaneously quantified using a custom-designed
multi-array electrochemiluminescence detection assay (Meso
Scale Discovery, Gaithersburg, USA) as described [22].
2.5. Data analysis and statistics
Graphical and statistical analysis was performed using Graph-
Pad Prism 7.01 (GraphPad Software, La Jolla, USA). Data was repre-
sented as means with standard error of means (SEM) shown to
indicate the uncertainty around the estimate of the group means.
Two-way ANOVA followed by a Dunnett’s or Tukey’s multiple com-
parison tests were used for the analysis of virus strain specific
effects on antibody and cytokine responses in the different infec-
tion groups. P values are indicated on figures.
Fig. 1. Alignment of translated E2 protein sequences from BVDV-1 Ho916, atypical pestivirus TKK and BVDV-1 reference strain C24V. Sequences were aligned using Clustalw
and distances calculated from construction of phylogenetic tree (PAM250) on MegAlign (DNA Star Inc.). Sequence distances calculated as divergence based on comparison of
sequence pairs in relation to a phylogeny reconstruction and as percent identity, which compares both sequences directly without accounting for phylogenetic relationships,
are presented in the tables.
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3.1. Assessment of virus-specific antibody responses
The Ho916 and Ho916/TKK infected groups mounted E2 specific
antibody response at 14 dpi (Fig. 3A) as determined by a competi-
tive BVDV ELISA. While the E2 specific antibody levels in the TKK
group increased from 14 dpi they were not above the cut-off until
21 dpi. The E2 specific antibody levels of the Ho916 and Ho916/
TKK groups were significantly higher than in the TKK group from
14 dpi. The Ho916 and Ho916/TKK groups showed NS3 antibody
responses (Fig. 3B) from 21 dpi compared to the control group,
whilst the TKK group responses were significantly higher compared
to the controls from 28 dpi but did not exceed the diagnostic cut-off
for assay positivity until 35 dpi. Ho916 group responses were sig-
nificantly greater than the TKK group at 21 and 28 dpi, whereas,
Ho916/TKK antibody levels were greater than TKK between 14
and 35 dpi. There were no significant differences in NS3 responses
between Ho916 and Ho916/TKK groups. Homologous neutraliza-
tion of both Ho916 and TKK viruses was observed from 14 dpi in
the single and co-infected groups. However, neutralization of
Ho916 virus by sera from TKK inoculated cattle only occurred at
low titres at 42 dpi while low titres of TKK- neutralizing antibodies
was observed in Ho916 inoculated animals from 21 dpi. We further
assessed the cross-neutralising properties of these sera by compar-
ing neutralisation of the inoculated viruses, and reference strainsBVDV-1a C24V, BVDV-2 50263-02-UK and BDV-1 S137/4
(Fig. 4A). Ho916 virus neutralization titres in both Ho916 and
Ho916/TKK group sera were higher than the TKK group sera and a
similar pattern was observed against C24V and BDV-1 but with
lower titres. In contrast, TKK virus was neutralized by TKK and
Ho916/TKK inoculated group sera but not by the Ho916 inoculated
animals’ sera. Neutralization of BVDV-2 was observed at low titres
in all inoculated groups with the lowest titres in sera from Ho916
inoculated animals. Ho916 and Ho916/TKK group sera better neu-
tralized BDV compared to sera from the TKK inoculated animals.
Assessment of cross-neutralisation, calculated as the percentage
of heterologous versus homologous neutralization, showed that
despite exhibiting weaker homologous neutralization, TKK group
sera showed comparatively good neutralization of Ho916, C24V
and BVDV-2 (Fig. 4B). Ho916 group sera showed cross-
neutralization of C24V albeit with lower titres compared to homol-
ogous neutralization. While cross-neutralization of all other viruses
by sera from the Ho916 inoculated animals was considerably less
than homologous virus neutralization. Cross-neutralization of
BDV-1 by sera from all inoculation groups was poor.
3.2. Assessment of virus-specific T cell responses
In comparison to uninfected controls, significant ex vivo PBMC
IFN-c responses were observed against Ho916 and TKK viruses
from 35 dpi (Fig. 5). PBMC from the Ho916 inoculated group
Fig. 2. Alignment of translated NS3 protein sequences from BVDV-1 Ho916, atypical pestivirus TKK and BVDV-1 reference strain C24V. Sequences were aligned using Clustalw
and distances calculated from construction of phylogenetic tree (PAM250) on MegAlign (DNA Star Inc.). Sequence distances calculated as divergence based on comparison of
sequence pairs in relation to a phylogeny reconstruction and as percent identity, which compares both sequences directly without accounting for phylogenetic relationships,
are presented in the tables.
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responses on 42 dpi, whilst responses in the TKK group significant
on 35 and 42 dpi. Responses to Ho916 virus in the Ho916/TKK
group were less than in the other two groups and were not statis-
tically significant. Responses to the TKK virus on the other hand,
were significant in both the TKK and Ho916/TKK groups at 35
and 42 dpi. Responses to the TKK virus by PBMC from the Ho916
group were not statistically significant. IFN-c responses to E2 pep-
tide pools at 42 dpi followed similar trends to the responses to
virus (Fig. 6A). IFN-c responses to the E2 peptide pool representing
Ho916 virus (E2-Ho916) were observed in the Ho916 and Ho916/
TKK groups but not in the TKK group. Responses to E2-TKK peptide
pool were seen in the TKK and Ho916/TKK groups, albeit only sta-
tistically significant in the TKK group. IFN-c responses to the NS3
peptide pool were observed in all infected groups and were statis-
tically significant in the Ho916 and TKK infected groups. Broadercytokine responses including IL-10, IL-4 and MIP-1bwere observed
following virus and peptide stimulation (Fig. 6B–D). TKK infected
animals were observed to elicit a broad cytokine response follow-
ing stimulation with homologous virus, as well as heterologous
virus. Significant quantities of IL-4, IL-10, and MIP-1b were
secreted by PBMC from TKK infected animals following TKK and
Ho916 stimulation. With the exception of MIP-1b, the other cytoki-
nes were not secreted to significant levels in the Ho916 infected
animals following stimulation with the TKK virus. While IL-4 pro-
duction was observed at lower levels in the co-infected animals in
response to both viruses, IL-10, and MIP-1bwere secreted in signif-
icant levels in this group following TKK stimulation. Significant IL-
4 responses to the E2-Ho916 were observed in the Ho916 virus and
co-infected groups and to the NS3 C24V peptide pool in the co-
infected group but not against E2-TKK in any of the infected
groups. IL-10 responses against NS3 and E2-TKK peptide pools
Fig. 3. Antigen-specific antibody responses of calves following experimental
infection with BVDV-1 Ho916, atypical bovine pestivirus TKK, co-infection with
both (Ho916/TKK) or uninfected controls. Longitudinal antibody responses were
measured by competitive ELISA against BVDV-1 (A) E2 and (B) NS3 proteins.
Antibody levels were calculated as % inhibition of antigen specific mAb binding, and
dashed lines denote positivity cut-off for the respective assays. Data represented as
means ± SEM; a two-way ANOVA with Dunnett’s post-test was performed and
statistical significances between infected and control groups are described by ‘a’
p < 0.0001, ‘b’ p < 0.001, and ‘c’ p < 0.01.
Fig. 4. Homologous and heterologous virus neutralising antibody titres of calves
following experimental infection with BVDV-1 Ho916, atypical bovine pestivirus
TKK, co-infection with both (Ho916/TKK) or uninfected controls. (A) Virus neutral-
ising antibody titres of serum pools collected at 42 dpi from the different infection
groups against Ho916, TKK, BVDV-1a Oregon C24V (C24V), BVDV-2 502643-02-UK
(BVDV-2) and BDV-1 S137/4 (BDV). (B) Cross-neutralization of heterologous virus
was calculated as a percentage of homologous neutralization by Ho916 or TKK
inoculated cattle.
Fig. 5. Longitudinal virus-specific IFN-c responses of calves following experimental
infection with BVDV-1 Ho916, atypical bovine pestivirus TKK, co-infection with
both (Ho916/TKK) or uninfected controls. Longitudinal PBMC IFN-c responses
following stimulation with (A) Ho916 and (B) TKK viruses were measured by ELISA
and adjusted for mock stimulated background responses. Data represented as group
means ± SEM; a two-way ANOVA with Dunnett’s post-test was performed and
statistical significances between infected and control groups are described by ‘a’
p < 0.0001, ‘b’ p < 0.001, and ‘c’ p < 0.01.
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peptide pool in the TKK infected group while the co-infected group
had significant responses to both E2 peptide pools and NS3. MIP-1b
responses were significant in all infected groups to E2-Ho916 and
NS3 and to E2-TKK in the TKK and co-infected groups.4. Discussion
Recent disease outbreaks within the EU, in Asia and South
America caused by atypical ruminant pestiviruses have highlighted
a group of viruses that have thus far received little attention. Com-
parative analyses of antigenic relationships between atypical rumi-
nant pestiviruses and BVDV-1 and BVDV-2 point towards the need
for improved diagnostics and reformulation of current vaccines for
the detection and control of these new viruses [7]. This study
aimed to increase the understanding of antigenic diversity on both
T cell and humoral responses to BVDV-1 and atypical pestiviruses.
In this study, both BVDV-1 E2 and NS3 specific antibody
responses were detected in all infected groups 14–21 dpi post-
infection albeit to a lesser extent in the TKK group. This raises
questions about the sensitive detection of antibodies against atyp-
ical ruminant pestiviruses, such as TKK, by diagnostic ELISAs
designed to detect antibodies against BVDV-1 [6]. This is supported
by the limited detection of antibodies to a European atypical
bovine pestivirus, Italy-1/10–1, using a commercial BVDV-1-
based ELISA, despite high neutralization titres [23]. In the present
study, NS3 antibodies were better detected than antibodies against
the less conserved E2 protein. It has recently been proposed that
diagnostics for BVDV and atypical pestiviruses should be based
on NS2/3 or Erns as they potentially possess more cross-reactive
epitopes, while assays targeting E2 may allow discrimination of
pestivirus species [7]. Homologous virus neutralization was
observed in all infected groups, yet cross-neutralization was only
Fig. 6. Antigen-specific cytokine responses of calves following experimental infection with BVDV-1 Ho916, atypical bovine pestivirus TKK, co-infection with both (Ho916/
TKK) or uninfected controls. PBMC isolated at 42 dpi were stimulated with Ho916, TKK viruses, peptide pools representing the Ho916 (E2-Ho916), TKK (E2-TKK) and C24V
(E2-C24V) E2 protein and NS3 protein from C24V (NS3-C24V) and secretion of (A) IFN-c, (B) IL-10, (C) IL-4 and (D) MIP-1bmeasured by a multiplex assay. Data represented as
group means ± SEM; a two-way ANOVA with Dunnett’s post-test was performed and statistical significances between infected and control groups are described by ‘a’ p <
0.0001, ‘b’ p < 0.001, ‘c’ p < 0.01, and ‘d’ p < 0.05.
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sera was able to neutralize the Ho916 virus almost to the same
extent as the homologous virus. The relatively low homologous
neutralizing antibody titres against TKK however, are suggestive
of an inferior antibody response compared to the more robust
titres in the Ho916 infected and co-infected groups. While similar
patterns of cross-neutralisation were observed between BVDV-1
and atypical pestivirus sera against BDV-1, atypical pestivirus
serum appeared to neutralize BVDV-2 better than BVDV-1 serum.
Limited cross neutralization activity, alluding to significant anti-
genic differences between BVDV-1 and -2 and atypical ruminant
pestiviruses have been previously reported [13,24,25].
A degree of cross-reactivity of T cell responses in TKK infected
animals after re-stimulation with Ho916 virus was observed. How-
ever, IFN-c responses to TKK virus were low in the Ho916 infected
group. IFN-c responses to E2 peptide pools were virus species
specific whilst responses to the more conserved NS3 target appear
to be maintained, to different extents, in all the infected groups.
Broader cytokine responses to E2 and NS3 peptide pools followed
similar trends to IFN-c. Responses to E2-Ho916 were not observed
in the TKK infected group, with the exception of MIP-1b. Similarly,
responses to E2-TKK were, by large, absent in the Ho916 group,
while as observed with IFN-c, a number of cytokine responses
were observed to the NS3 peptide pool in all the infected groups.
These observations, taken together, point towards E2 responses
being virus specific, with responses to the NS3 antigen being better
conserved between the viruses.
The limited T cell and antibody immune reactivity of Ho916
inoculated animals to Th/04_KhonKaen suggests that animalsvaccinated with BVDV-1-based vaccines may not be protected
against atypical ruminant pestiviruses. There is discussion on
whether atypical ruminant pestiviruses should be recognized as a
third BVDV species and if so, what implications this might have,
from a regulatory point of view, for currently licensed BVD diag-
nostics and vaccines as well as for the BVDV control programmes
and eradication status of countries and regions [26]. There is
increasing evidence of the clinical and epidemiological relevance
of these emerging viruses with clinical disease following experi-
mental infection in cattle and sheep and reports of natural infec-
tions in Southeast Asia, South America and Europe [5]. Antigenic
variation between BVDV-1 and -2 species has already led to the
inclusion of BVDV-2 strains in some vaccines [27], and this needs
to be considered in the case of atypical ruminant pestiviruses. Vac-
cine efficacy studies should also include challenge with heterotypic
BVDV isolates as well as novel antigenically distinct variants [28].
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